120 related articles for article (PubMed ID: 35864156)
21. Prognostic impact of perirenal fat or adrenal gland involvement in patients with pT3b renal cell carcinoma.
Fujita T; Iwamura M; Yanagisawa N; Muramoto M; Hirayama T; Okayasu I; Baba S
Urology; 2007 May; 69(5):839-42. PubMed ID: 17482918
[TBL] [Abstract][Full Text] [Related]
22. Utility of pT3 substaging in lymph node-negative urothelial carcinoma of the bladder: do pathologic parameters add to prognostic sub-stratification?
Maas M; Mischinger J; Compérat E; Scharpf M; Fend F; Todenhöfer T; Stenzl A; Gakis G; Rausch S
World J Urol; 2021 Nov; 39(11):4021-4027. PubMed ID: 33881556
[TBL] [Abstract][Full Text] [Related]
23. Seminal vesicle invasion combined with extraprostatic extension is associated with higher frequency of biochemical recurrence and lymph node metastasis than seminal vesicle invasion alone: Proposal for further pT3 prostate cancer subclassification.
Rehman A; El-Zaatari ZM; Han SH; Shen SS; Ayala AG; Miles B; Divatia MK; Ketcham MS; Chung BM; Rogers JT; Ro JY
Ann Diagn Pathol; 2020 Dec; 49():151611. PubMed ID: 32956915
[TBL] [Abstract][Full Text] [Related]
24. Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomy.
Steuber T; Erbersdobler A; Graefen M; Haese A; Huland H; Karakiewicz PI
Cancer; 2006 Feb; 106(4):775-82. PubMed ID: 16400637
[TBL] [Abstract][Full Text] [Related]
25. Reassessment of prognostic heterogeneity of pT3 renal pelvic urothelial carcinoma: analysis in terms of proposed pT3 subclassification systems.
Park J; Habuchi T; Arai Y; Ohyama C; Inoue T; Hatakeyama S; Jeon SS; Kwon GY; Kwak C; Moon KC; Kim CS; Ahn H
J Urol; 2014 Oct; 192(4):1064-71. PubMed ID: 24735938
[TBL] [Abstract][Full Text] [Related]
26. Textural differences based on apparent diffusion coefficient maps for discriminating pT3 subclasses of rectal adenocarcinoma.
Lu ZH; Xia KJ; Jiang H; Jiang JL; Wu M
World J Clin Cases; 2021 Aug; 9(24):6987-6998. PubMed ID: 34540954
[TBL] [Abstract][Full Text] [Related]
27. Natural history of surgically treated bladder carcinoma with extravesical tumor extension.
Quek ML; Stein JP; Clark PE; Daneshmand S; Miranda G; Cai J; Groshen S; Lieskovsky G; Quinn DI; Raghavan D; Skinner DG
Cancer; 2003 Sep; 98(5):955-61. PubMed ID: 12942562
[TBL] [Abstract][Full Text] [Related]
28. [Stage pT3 prostatic cancer after radical prostatectomy. Results in progression and survival].
Gil Martínez P; Gil Sanz MJ; Allepuz Losa C; Borque Fernando A; Valdivia Navarro P; Rioja Sanz LA
Actas Urol Esp; 2000 May; 24(5):400-5. PubMed ID: 10965576
[TBL] [Abstract][Full Text] [Related]
29. Comparison of microscopic (pT3a) and gross extravesical extension (pT3b) in pathological staging of bladder cancer: analysis of patient outcomes.
Dincel C; Kara C; Balci U; Ozer K; Ozbir S; Sefik E; Gorgel SN; Girgin C
Int Urol Nephrol; 2013 Apr; 45(2):387-93. PubMed ID: 23338846
[TBL] [Abstract][Full Text] [Related]
30. A modified TNM-7 staging system to better predict the survival in patients with hepatocellular carcinoma after hepatectomy.
Huang J; Zhang Y; Peng Z; Gao H; Xu L; Jiao LR; Chen M
J Cancer Res Clin Oncol; 2013 Oct; 139(10):1709-19. PubMed ID: 23982274
[TBL] [Abstract][Full Text] [Related]
31. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733
[TBL] [Abstract][Full Text] [Related]
32. The ability of the American Joint Committee on Cancer Staging system to predict progression-free survival after radical prostatectomy.
May F; Hartung R; Breul J
BJU Int; 2001 Nov; 88(7):702-7. PubMed ID: 11890240
[TBL] [Abstract][Full Text] [Related]
33. Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a?
Thompson RH; Leibovich BC; Cheville JC; Lohse CM; Frank I; Kwon ED; Zincke H; Blute ML
J Urol; 2005 Mar; 173(3):918-21. PubMed ID: 15711327
[TBL] [Abstract][Full Text] [Related]
34. pT3 Substaging is a prognostic indicator for lymph node negative urothelial carcinoma of the bladder.
Tilki D; Svatek RS; Karakiewicz PI; Novara G; Seitz M; Sonpavde G; Gupta A; Kassouf W; Fradet Y; Ficarra V; Skinner E; Lotan Y; Sagalowsky AI; Stief CG; Reich O; Shariat SF
J Urol; 2010 Aug; 184(2):470-4. PubMed ID: 20620401
[TBL] [Abstract][Full Text] [Related]
35. The value of tumour spread, grading and growth pattern as morphological predictive parameters in bladder carcinoma. A critical revision of the 1987 TNM classification.
Angulo JC; Lopez JI; Flores N; Toledo JD
J Cancer Res Clin Oncol; 1993; 119(10):578-93. PubMed ID: 8335677
[TBL] [Abstract][Full Text] [Related]
36. Challenges in Pathologic Staging of Bladder Cancer: Proposals for Fresh Approaches of Assessing Pathologic Stage in Light of Recent Studies and Observations Pertaining to Bladder Histoanatomic Variances.
Paner GP; Montironi R; Amin MB
Adv Anat Pathol; 2017 May; 24(3):113-127. PubMed ID: 28398951
[TBL] [Abstract][Full Text] [Related]
37. Current TNM classification of renal cell carcinoma evaluated: revising stage T3a.
Siemer S; Lehmann J; Loch A; Becker F; Stein U; Schneider G; Ziegler M; Stöckle M
J Urol; 2005 Jan; 173(1):33-7. PubMed ID: 15592020
[TBL] [Abstract][Full Text] [Related]
38. Impact of Lymphovascular Invasion on Overall Survival in Patients With Prostate Cancer Following Radical Prostatectomy: Stage-per-Stage Analysis.
Jamil M; Rakic N; Sood A; Keeley J; Modonutti D; Novara G; Jeong W; Menon M; Rogers CG; Abdollah F
Clin Genitourin Cancer; 2021 Oct; 19(5):e319-e325. PubMed ID: 34154946
[TBL] [Abstract][Full Text] [Related]
39. The Clinical Significance of pT3a Lesions as Well as Unilateral Versus Bilateral Invasion Into the Seminal Vesicle in Men With pT3b Prostate Cancer: A Proposal for a New pT3b Subclassification.
Teramoto Y; Numbere N; Wang Y; Miyamoto H
Arch Pathol Lab Med; 2023 Nov; 147(11):1261-1267. PubMed ID: 36656173
[TBL] [Abstract][Full Text] [Related]
40. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
